CO5040228A1 - Nuevos derivados del acido carboxilico y su obtencion . - Google Patents
Nuevos derivados del acido carboxilico y su obtencion .Info
- Publication number
- CO5040228A1 CO5040228A1 CO96047377A CO96047377A CO5040228A1 CO 5040228 A1 CO5040228 A1 CO 5040228A1 CO 96047377 A CO96047377 A CO 96047377A CO 96047377 A CO96047377 A CO 96047377A CO 5040228 A1 CO5040228 A1 CO 5040228A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- alkylthio
- naphthyl
- alkoxy
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/616—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Derivados del ácido carboxílico de la fórmula IEn la que R1 significa un tetrazol, nitrilo, un grupo COOH o un radical COOH hidrolizable, y los otros sustituyentes tienen los siguientes significados:R2 y R3 (que pueden ser idénticos o diferentes):Fenilo o naftilo, que puede estar sustituido por uno o varios de los siguientes radicales: Halógeno, ciano, NO2 , hidroxi, C1 -C4 -alquilo, C1 -C4 -halógenoalquilo, C1 -C4 -alcoxi, C1 -C4 - halógenoalcoxi, fenoxi, C1 -C4 -alquiltio, amino, benciloxi, C1 -C4 -dialquilamino; ó fenilo o naftilo que están unidos entre sí en posición orto por vía de un enlace directo, un grupo metileno, etileno o etinileno, un átomo de oxígeno o de azufre;R4 fenilo o naftilo, metilendioxifenilo, etilendioxifenilo, indanilo, indolilo, piridilo, benzopiranilo, furanilo, benzofuranilo, isooxazolilo, isotiazolilo, 1, 3, 4-tiadiazolilo, pirimidinilo, 2,3-dihidrobenzofuranilo, benzotienilo, quinolinilo, C3 -C7 -cicloalquilo, tienilo, oxazolilo, tiazolilo, que pueden estar sustituidos por uno o varios de los siguientes radicales: halógeno, ciano, hidroxi, NO2 , C1 -C4 alquilo, C1 -C4 -halógenoalquilo, C1 -C4 -alcoxi, C1 -C4 -halogenoalcoxi, fenoxi, C1 -C4 -alquiltio, amino, beciloxi, C1 -C4 - alquilamino o C1 -C4 -dialquilamino, pudiendo los radicales alquilo formar juntos un anillo;R5 C1 -C8 alquilo, C3 -C6 -alquenilo, C3 -C6 -alquinilo o C3 -C8 -cicloalquilo, cuyos radicales pueden estar mono o polisustituidos por: halógeno, C1 -C4 -alcoxi, C1 -C4 -alquiltio, C1 -C4 -alquilamino, di-C1 -C4 -alquilamino;fenilo, bencilo, 1-metilnaftilo, 2-metilnaftilo o naftilo, que puede estar sustituidos cada vez por uno o varios de los siguientes radicales: halógeno, ciano, hidroxi, amino, C1 -C4 -alquilo, C1 -C4 - alcoxi, fenoxi, C1 -C4 -alquiltio, dioximetileno o dioxoetileno;n 1 - 2.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19533025A DE19533025A1 (de) | 1995-09-07 | 1995-09-07 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5040228A1 true CO5040228A1 (es) | 2001-05-29 |
Family
ID=7771490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96047377A CO5040228A1 (es) | 1995-09-07 | 1996-09-05 | Nuevos derivados del acido carboxilico y su obtencion . |
Country Status (30)
Country | Link |
---|---|
US (1) | US6004988A (es) |
EP (1) | EP0862550B1 (es) |
JP (1) | JPH11512104A (es) |
KR (1) | KR19990044455A (es) |
CN (1) | CN1070841C (es) |
AR (1) | AR003532A1 (es) |
AT (1) | ATE197448T1 (es) |
AU (1) | AU705956B2 (es) |
BG (1) | BG63720B1 (es) |
BR (1) | BR9610139A (es) |
CA (1) | CA2228002A1 (es) |
CO (1) | CO5040228A1 (es) |
CZ (1) | CZ64198A3 (es) |
DE (2) | DE19533025A1 (es) |
ES (1) | ES2153124T3 (es) |
GR (1) | GR3034797T3 (es) |
HR (1) | HRP960400B1 (es) |
HU (1) | HUP9802329A3 (es) |
IL (1) | IL123213A (es) |
MY (1) | MY132151A (es) |
NO (1) | NO310651B1 (es) |
NZ (1) | NZ316940A (es) |
PL (1) | PL325398A1 (es) |
PT (1) | PT862550E (es) |
RU (1) | RU2175315C2 (es) |
SI (1) | SI0862550T1 (es) |
SK (1) | SK282082B6 (es) |
TR (1) | TR199800410T1 (es) |
WO (1) | WO1997009294A1 (es) |
ZA (1) | ZA967537B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
US7057057B2 (en) | 2002-05-22 | 2006-06-06 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-ketoepoxide compounds |
JP2006508986A (ja) | 2002-11-20 | 2006-03-16 | エルラント ゲネ セラペウチクス エルエルシー | ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4224572C2 (de) * | 1992-07-24 | 1996-04-18 | Sfs Ind Holding Ag | Befestigungselement zum Einsatz in Beton oder dgl. Material |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
-
1995
- 1995-09-07 DE DE19533025A patent/DE19533025A1/de not_active Withdrawn
-
1996
- 1996-08-29 BR BR9610139A patent/BR9610139A/pt not_active Application Discontinuation
- 1996-08-29 CZ CZ98641A patent/CZ64198A3/cs unknown
- 1996-08-29 PT PT96930125T patent/PT862550E/pt unknown
- 1996-08-29 AT AT96930125T patent/ATE197448T1/de not_active IP Right Cessation
- 1996-08-29 ES ES96930125T patent/ES2153124T3/es not_active Expired - Lifetime
- 1996-08-29 SI SI9630188T patent/SI0862550T1/xx unknown
- 1996-08-29 HU HU9802329A patent/HUP9802329A3/hu unknown
- 1996-08-29 US US09/029,447 patent/US6004988A/en not_active Expired - Fee Related
- 1996-08-29 DE DE59606132T patent/DE59606132D1/de not_active Expired - Fee Related
- 1996-08-29 NZ NZ316940A patent/NZ316940A/xx unknown
- 1996-08-29 WO PCT/EP1996/003793 patent/WO1997009294A1/de active IP Right Grant
- 1996-08-29 CN CN96197840A patent/CN1070841C/zh not_active Expired - Fee Related
- 1996-08-29 SK SK282-98A patent/SK282082B6/sk unknown
- 1996-08-29 RU RU98106478/04A patent/RU2175315C2/ru not_active IP Right Cessation
- 1996-08-29 PL PL96325398A patent/PL325398A1/xx unknown
- 1996-08-29 TR TR1998/00410T patent/TR199800410T1/xx unknown
- 1996-08-29 AU AU69295/96A patent/AU705956B2/en not_active Ceased
- 1996-08-29 IL IL12321396A patent/IL123213A/xx not_active IP Right Cessation
- 1996-08-29 JP JP9510830A patent/JPH11512104A/ja not_active Abandoned
- 1996-08-29 CA CA002228002A patent/CA2228002A1/en not_active Abandoned
- 1996-08-29 EP EP96930125A patent/EP0862550B1/de not_active Expired - Lifetime
- 1996-08-29 KR KR1019980701703A patent/KR19990044455A/ko active IP Right Grant
- 1996-09-03 HR HR960400A patent/HRP960400B1/xx not_active IP Right Cessation
- 1996-09-04 MY MYPI96003669A patent/MY132151A/en unknown
- 1996-09-05 CO CO96047377A patent/CO5040228A1/es unknown
- 1996-09-06 AR ARP960104272A patent/AR003532A1/es unknown
- 1996-09-06 ZA ZA9607537A patent/ZA967537B/xx unknown
-
1998
- 1998-03-06 NO NO19981002A patent/NO310651B1/no not_active IP Right Cessation
- 1998-03-24 BG BG102347A patent/BG63720B1/bg unknown
-
2000
- 2000-11-09 GR GR20000402475T patent/GR3034797T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR039566A1 (es) | Inhibidores de la histona deacetilasa, composicion farmaceutica que los contiene y sus procesos de preparacion | |
RS50808B (sr) | Postupak sinteze perindoprila i njegovih farmaceutski prihvatljivih soli | |
ATE284853T1 (de) | Ureido-thiobuttersäurederivate als ppar-agonisten | |
ES2192520T3 (es) | Composicion farmaceutica. | |
NO20014485D0 (no) | Nye forbindelser og sammensetninger som proteaseinhibitorer | |
CO5550450A2 (es) | Derivados de 1-acil-pirrolidina para el tratamiento de infec ciones virales | |
CO5611195A2 (es) | Novedosos inhibidores de la gamma secretasa | |
ES2190115T3 (es) | Derivados de acido hidroxamico y carboxilico con actividad inhibidora de mmp y tnf. | |
ID18143A (id) | Penghambat metaloprotease amina siklik tersubstitusi | |
CO4700521A1 (es) | Esteres y amidas de 1,4-piperidina di-sustituida | |
ATE326454T1 (de) | Neue bernsteinsäure derivative als cysteine- protease-inhibitoren | |
CO4970713A1 (es) | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen | |
ATE377010T1 (de) | Caspase-inhibitoren und ihre verwendungen | |
PE20060298A1 (es) | Derivados de acido carboxilico de bencimidazolona | |
DE69928697D1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
CY1112800T1 (el) | Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας | |
CO5040228A1 (es) | Nuevos derivados del acido carboxilico y su obtencion . | |
RU2008151757A (ru) | Пероральная композиция, содержащая 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1, 2-бензизоксазол-6-ил)метокси]фенил}пропионовую кислоту или ее соль | |
DK0984938T3 (da) | Cyanoguanidiner som celleproliferationsinhibitorer | |
EA199900057A1 (ru) | Ингибиторы матриксных металлопротеиназ | |
PE20020157A1 (es) | Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis | |
LU90758I2 (fr) | Almotriptan et ses sels pharmaceutiquement acceptables | |
DE69933855D1 (de) | Indolderivate zum nachweis von peptidasen von mikroorganismen | |
AR068372A1 (es) | Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen | |
ATE299861T1 (de) | Ppar-(gamma) agonisten zur behandlung von type ii diabetes |